Key result
Transcatheter aortic valve replacement (TAVR) is beneficial over surgical aortic valve replacement in certain patient populations with severe aortic valve stenosis.
TAVR is a beneficial alternative to surgical aortic valve replacement for certain patients with severe aortic stenosis, requiring a multidisciplinary team approach.
Multidisciplinary TAVR teams may aid candidate selection; Level 5 evidence leaves open outcome benefits versus standard care.
Transcatheter aortic valve replacement (TAVR) is considered a lower-risk procedure for patients with severe aortic valve stenosis. Several FDA-approved trials performed in the United States support TAVR to be beneficial over surgical aortic valve replacement in certain patient populations. An optimal TAVR program consists of a multidisciplinary team that selects candidates for the procedure based on shared decision-making and the patient's anatomy and risk factors, and follows the patients through the Transcatheter Valve Therapy National Registry.
No takes yet. Share an insight, caveat, or question.
Christine A. Rullo (2021) conducted a review in severe aortic valve stenosis. Transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement was evaluated. Transcatheter aortic valve replacement (TAVR) is beneficial over surgical aortic valve replacement in certain patient populations with severe aortic valve stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: